4//SEC Filing
Larsen Charles 4
Accession 0001140361-25-041720
CIK 0001339005other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:27 PM ET
Size
14.2 KB
Accession
0001140361-25-041720
Insider Transaction Report
Form 4
FEMASYS INCFEMY
Larsen Charles
Director
Transactions
- Discretionary Transaction
Senior Secured Convertible Notes
2025-11-07Exercise: $0.73From: 2025-11-07Exp: 2035-11-07→ Common stock, par value $0.001 per share (34,122 underlying) - Discretionary Transaction
Series A-1 Warrants
2025-11-07+34,122→ 34,122 totalExercise: $0.81From: 2025-11-07Exp: 2035-11-07→ Common stock, par value $0.001 per share (34,122 underlying) - Discretionary Transaction
Series B-1 Warrants
2025-11-07+34,122→ 34,122 totalExercise: $0.92From: 2025-11-07Exp: 2035-11-07→ Common stock, par value $0.001 per share (34,122 underlying) - Discretionary Transaction
Series C-1 Warrants
2025-11-07+34,122→ 34,122 totalExercise: $1.10From: 2025-11-07Exp: 2035-11-07→ Common stock, par value $0.001 per share (34,122 underlying)
Footnotes (7)
- [F1]Holder may, at its option, prior to maturity, convert all or any portion of the outstanding amount of Senior Secured Convertible Notes due 2035 (the "Convertible Notes"), including accrued paid in-kind interest thereon, subject to certain limitations, into shares of Common Stock, at an initial conversion price of $0.73 per share of Common Stock. The conversion rate is subject to adjustment in accordance with the terms of the Convertible Notes and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- [F2]Holder may, at its option, exercise the Series A-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.81 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series A-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- [F3]Holder may, at its option, exercise the Series B-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.92 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series B-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- [F4]Holder may, at its option, exercise the Series C-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $1.10 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series C-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- [F5]Represents the maximum number of shares of Common Stock issuable upon the voluntary conversion of the original stated amount of the Convertible Notes. The number of shares issuable upon conversion of the Convertible Notes is subject to increase in connection with the accrual of interest, which is payable in kind. The Holder's ability to convert the Convertible Notes to shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
- [F6]The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
- [F7]The reported securities were purchased by the reporting person for an aggregate amount of $25,000.
Documents
Issuer
FEMASYS INC
CIK 0001339005
Entity typeother
Related Parties
1- filerCIK 0001857458
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:27 PM ET
- Size
- 14.2 KB